In the past century, modern cancer medicine has never made such exciting achievements. The leap from chemotherapy to targeted treatment has promoted the measurement unit of cancer patients' survival from "month" to "year". The development from targeted therapy to immunotherapy has created the possibility of complete cure and long-term survival of patients. This is probably the most detailed version of cancer drug treatment guidelines.
1. Targeted drugs for lung cancer
1.1 Non small cell lung cancer
1.2 Small cell lung cancer
2. Colorectal cancer
3. Breast cancer
4. Gastric and esophageal cancer
5. Soft tissue sarcoma
5.1 Gastrointestinal stromal tumors
5.2 Desmoid tumor
5.3 Pigmented villonodular synovitis/giant cell tumor of tendon sheath
5.4 Angiosarcoma
5.5 Solitary fibroma/hemangiopericytoma
5.6 Alveolar soft tissue sarcoma
5.7 Inflammatory myofibroblastoma
5.8 Undifferentiated pleomorphic sarcoma
5.9 Highly differentiated/dedifferentiated retroperitoneal liposarcoma
5.10 Perivascular epithelioid cell tumor/recurrent vascular muscle
Lipoma/Lymphangioleiomyoma
6. Hepatocellular carcinoma
7. Pancreatic tumor
7.1 Pancreatic adenocarcinoma
7.2 Pancreatic neuroendocrine tumors
8. Ovarian cancer, fallopian tube cancer, peritoneal cancer
9. Cervical cancer
10. Endometrial carcinoma/sarcoma
11. Central nervous system tumors
12. Thyroid cancer
13. Renal cancer
14. Bladder cancer (including urothelial carcinoma)
15. Head and neck cancer
16. Melanoma
17. Basal cell carcinoma
18. Lymphoma
19. Leukemia
20. Thymoma/cancer
21. Merkel cell carcinoma
22. Chordoma
23. Multiple myeloma
24. Pan tumor targeting and immunodrugs
Source link:
https://www.cn-healthcare.com/articlewm/20221008/content-1446621.html
